(UTHR) |
| 0 (0%) 05-29 15:06 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 609.35 |
| Resistance 1: | 585.98 |
| Pivot price: | 568.91 |
| Support 1: | 548.17 |
| Support 2: | 456.08 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 27.060 |
| Book Value | 139.980 |
| PEG Ratio | 2.36 |
| Gross Profit | 64.547 |
| Profit Margin (%) | 40.62 |
| Operating Margin (%) | 41.69 |
| Return on Assets (ttm) | 12.6 |
| Return on Equity (ttm) | 20.3 |
Company news
Fri, 29 May 2026
2 Mid-Cap Stocks on Our Buy List and 1 We Turn Down - The Globe and Mail
Thu, 28 May 2026
UTHR holds as Tyvaso shows 33% lower worsening risk in rare lung scarring disease - MSN
Wed, 27 May 2026
United Therapeutics(UTHR.US) Officer Sells US$4.58 Million in Common Stock - Moomoo
Wed, 27 May 2026
(UTHR) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Tue, 26 May 2026
Assessing United Therapeutics (UTHR) Valuation After Strong Recent Shareholder Returns - simplywall.st
Mon, 25 May 2026
United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 17% Potential Upside for Investors - DirectorsTalk Interviews
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
